Total planned funding: $868,709,135
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $157,057,625 |
Uganda | $150,227,368 |
Kenya | $142,409,028 |
Tanzania | $99,617,259 |
Zambia | $97,285,576 |
South Africa | $38,103,802 |
Mozambique | $34,477,743 |
Zimbabwe | $31,281,462 |
Rwanda | $28,531,438 |
Côte d'Ivoire | $25,827,449 |
Haiti | $21,160,859 |
Vietnam | $14,047,428 |
Democratic Republic of the Congo | $11,672,026 |
Botswana | $6,136,487 |
Ethiopia | $3,784,817 |
Guyana | $2,121,954 |
Eswatini | $2,120,493 |
Namibia | $1,401,202 |
Burundi | $765,195 |
South Sudan | $283,942 |
Cameroon | $163,101 |
Ukraine | $132,881 |
Dominican Republic | $100,000 |
Malawi | $0 |
Lesotho | $0 |
Organizational Types
Private Contractor | $602,768,418 |
NGO | $80,372,763 |
Host Country Government Agency | $72,623,385 |
Unknown | $67,307,999 |
Implementing Agency | $34,317,475 |
Own Agency | $3,535,888 |
FBO | $3,382,295 |
University | $3,317,286 |
Parastatal | $1,073,626 |
Other USG Agency | $10,000 |
Multi-lateral Agency | $0 |
Program Areas
Treatment | $868,709,135 |
Budget Codes
HTXD: Treatment: ARV Drugs | $868,709,135 |
Top Partner Programs
Chemonics International:
$408,852,842
View countries